Novartis struck a collaboration with macrocycle biotech Unnatural Products targeting cardiovascular therapies, potentially worth up to $1.7 billion in milestones.
Longevity News
Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal...
Source: FierceBiotech - All • Published: 18 Feb 2026, 15:47
Continue exploring
Related longevity signals
Nature - MainHuman brain organoids record the passage of time over multiple years - NatureReports multi‑year human cerebral organoid cultures that continue cell‑type specific maturation and record elapsed time via transcriptional and epigenomic changes.Fight Aging!Bacterial Lipoic Acid Protein Ligase A Improves Mammalian Mitochondrial Function and HealthThis article previews research on using a bacterial enzyme to boost mitochondrial protein modification and overall cellular energy, framed as a potential metabolic-enhancing therapy. It invites readers curious about cross-species gene therapy approaches aimed at improving healthspan and age-related function.Nature - BiotechnologySEQURNA enhances FLASH-seq gene detection while eliminating DTT dependenceSEQURNA-focused methods article presenting a comparative benchmark of a synthetic thermostable RNase inhibitor for improved single-cell, full-length RNA-seq workflows.Longevity TechnologyClaremedica’s digital test finds 90% of new dementia cases earlyA report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.